P atient-reported outcome measures (PROs) have become the standard measure of treatment effectiveness in ABBREVIATIONS: D3, day 3; DDD, degenerative disc disease; EQ5D, EuroQol 5D; FU, follow-up; HRQoL, health-related quality of life; MCID, minimum clinically important difference; ODI, Oswestry Disability Index; OFI, objective functional impairment; PCS, Physical Component Summary; PRO, patient-reported outcome measure; RMDI, Roland-Morris Disability Index; SF-12, Short Form 12; TUG Test, Time Up and Go Test; VAS, Visual Analog Scale patients undergoing spine surgery for degenerative disc disease (DDD). 1 Outcome assessment in lumbar DDD does not only assist in monitoring safety and treatment efficacy of any surgical or nonsurgical treatment, but is also useful for comparing different treatment strategies. 2 One of the major drawbacks of well-established PROs (eg, Oswestry Disability Index [ODI] and Roland-Morris Disability Index [RMDI] for functional impairment and Short Form 36, Short Form 12 , and EuroQol 5D [EQ5D] for health-related quality of life [HRQoL] ) is their limited comparability. Patients may rate their subjective pain or functional disability differently for reasons of educational, cultural, and motivational interindividual differences. 3 Altogether, there is a dearth of objective, or at least less subjective, measures of functional disability to aid the process of clinical decision making in lumbar DDD. Currently, the only existing objective clinical outcome measures are the measurement of range of movement (eg, with a goniometer), the measurement of absolute muscle strength (eg, with a newton meter), or the measurement of walking speed and distance. 3, 4 New objective outcome measures have been tested using an advanced tracking technology based on global positioning systems. Thus far, none of these measurements have been adopted into daily clinical routine. 5, 6 We recently presented the validation of a simple test, the Timed Up and Go Test (TUG Test), as a measurement tool of objective functional impairment (OFI) with an excellent intra-and interrater reliability. 4, 7 The validity of the TUG Test was demonstrated with good correlation with the Visual Analog Scale (VAS) back and leg pain and functional impairment indexes (RMDI and ODI), as well as with HRQoL. The upper limit of "normal" was determined as 11.5 s, and the corresponding OFI could be categorized as mild, moderate, and severe OFI according to age, sex, and TUG Test time performance. 7 Although all established PROs deliver specific numeric values of pain intensity, functional impairment, and HRQoL, the scores do not directly translate into clinically meaningful improvement. 1 Thus, the concept of the minimum clinically important difference (MCID) was established and later introduced as a critical threshold to define/determine treatment effectiveness. 1, 8 The original conceptualization of MCID was an implicit ratio to weigh benefits and risks of treatment. 9 Currently, MCID research mainly focuses on the benefit side of this ratio and most commonly considers MCID to be "the smallest change that is important to patients." 10 So far, several studies have reported a range of different MCIDs for established PROs in different patient populations with various spinal pathologies. 1 The aim of this study was to assess the MCID of the TUG Test as a measure of functional impairment for patients undergoing surgery for lumbar DDD.
METHODS
Patients were prospectively enrolled at the Departments of Neurosurgery of the University Hospital Geneva and the Cantonal Hospital St. Gallen in Switzerland between September 2013 and April 2015. Patients were scheduled for lumbar spine surgery for the following diagnoses: (1) lumbar disc herniation, (2) lumbar spinal stenosis, and (3) lumbar DDD with or without instability requiring lumbar fusion (transforaminal lumbar interbody fusion, posterior lumbar interbody fusion, or extreme lateral interbody fusion). Exclusion criteria were age younger than 18 years, pregnancy, severe neurological deficits, or other medical reasons interfering with the patients' ability to walk and perform the TUG Test (eg, Parkinson disease, wheelchair user, severe congestive heart failure). Patient demographic data (age, sex, size, weight, body mass index, and working status) as well as clinical data (British Medical Research Council muscle strength of index muscles of the lower extremities, smoking status, and previous surgery) were obtained preoperatively. VAS back and leg pain scores, RMDI and ODI questionnaires, and the SF-12 (including both physical and mental component summary [PCS and MCS] scores), and EQ5D questionnaires were recorded, and a single TUG Test was performed at baseline, day 3 (D3), and at week 6 (W6) of follow-up (FU). There were 4 qualified raters who performed the TUG Test, including 3 residents in advanced training and 1 board-certified staff neurosurgeon.
Ethics Approval
The study was approved by the Institutional Review Board of the University of Geneva (14-079) and the Ethics Committee St. Gallen (14/049). Written informed consent was obtained from every study participant.
Statistical Analysis
TUG Test times and various subjective outcome measures at baseline, D3, and W6 were compared using t tests. Previously established PROs, including pain intensity (VAS back and leg pain scores), functional impairment (ODI and RMDI), and HRQoL (EQ5D index and SF-12 PCS score) were used as anchors according to the method of Parker et al. 1 Responder status to surgical treatment was defined at the W6 FU using previously published MCID values for an ODI of 12.8, RMDI of 5.0, PCS of 4.9, EQ5D index of 0.359, VAS leg pain score of 1.6, and VAS back pain score of 1.2 to generate a binary responder and nonresponder variable.
8,10-13 Three previously published anchor-based approaches were used to assess the MCID after lumbar spine surgery. 1 According to Parker et al, 1 we computed the MCID based on specified definitions using the previously mentioned anchors: Method (1) The average change approach defines the MCID as the average change in the study cohort defined as responders. Method (2) The minimum detectable change approach defines the MCID as the smallest change that can be considered above the measurement error. The MCID is thus equal to the upper value of the 95% confidence interval for the average change score seen in the study cohort defined as nonresponders. Method (3) The change difference approach defines the MCID as the difference in the average change score for responders and nonresponders. These methods produce a multitude of MCIDs, and although there is no consensus on the optimal method, we built the average of all MCIDs to determine the clinically used MCID.
Data were analyzed using Stata version 14.0 (StataCorp, College Station, Texas). Statistical significance was accepted at P < .05.
RESULTS
The patient cohort included 100 patients (43 female patients, 43.0%) with a mean ± SD age of 56.2 ± 16.1 years. Before hospitalization, 44 patients (44.0%) worked full or part time, 16 patients (16.0%) were not working, 3 patients (3.0%) were disabled, and 37 patients (37.0%) were retired. Forty-five patients (45.0%) underwent microdiscectomy for lumbar disc herniation or recurrent lumbar disc herniation, 35 patients (35.0%) underwent a uni-or bilateral decompression for lumbar spinal stenosis, and 20 patients (20.0%) underwent a lumbar fusion procedure. At the W6 FU, statistically significant improvement (P < .001) was observed for the following PROs assessed: VAS back and leg pain scores (mean improvement, −2.5 ± 2.9 and −4.5 ± 3.3, respectively), ODI (−24.6 ± 17.4), RMDI (−6.4 ± 6.1), EQ5D index (+0.304 ± 0.249), SF-12 PCS (+9.2 ± 9.1), and SF-12 MCS (+6.2 ± 9.6). Also, the TUG Test time revealed a significant mean improvement (−3.5 ± 4.6 s, P < .001).
Subjective and objective measures (mean ± SD values) are shown in Table 1 . All subjective outcome measures except SF-12 MCS significantly improved at D3 after the surgery. The mean TUG Test time did not improve significantly in the early postoperative period (10.1 ± 5.0 s preoperatively compared with 9.4 ± 4.5 s at D3 [P = .32]). From D3 to the W6 FU, all subjective and objective outcome measures significantly improved (P < .003) except VAS leg pain score, which already had improved to its maximum at D3 (Table 1) .
Sixty-one patients (61%) and 82 patients (82%) were responders according to the MCID for VAS back and leg pain, respectively. Seventy-three patients (73%) and 61 patients (61%) were responders according to the MCID for the ODI and RMDI, respectively. Forty-three patients (43%), 29 patients (29%), and 38 patients (38%) were responders according to the MCID for the EQ5D index, the SF-12 PCS, and the SF-12 MCS, respectively. Using VAS back pain score as an anchor, the MCID threshold for the TUG Test time ranged from 1.3 to 5.3 s depending on the computation method (Table 2 ). Using the VAS leg pain score as an anchor, the MCID threshold for the TUG Test time ranged from 1.3 to 4.8 s depending on the computation method. Using the ODI as an anchor, the MCID threshold for the TUG Test ranged from 0.9 to 4.8 s depending on the computation method. Using the RMDI as an anchor, the MCID threshold for the TUG Test time ranged from 1.5 to 5.1 s depending on the computation method. Using the EQ5D index as an anchor, the MCID threshold ranged from 1.7 to 6.0 s depending on the computation method. Finally, using the SF-12 PCS as an anchor, the MCID threshold for the TUG Test time ranged from 2.0 to 3.4 s depending on the computation method. For all anchors except the SF-12 PCS, the largest threshold was always derived from the minimum detectable change approach, whereas the smallest threshold was always derived from the change difference approach. The mean MCID for all methods and for all measured PROs was 3.4 s.
DISCUSSION
This study aimed to determine the MCID of the TUG Test time as a measure of OFI in lumbar DDD. An average of (Table 3) .
Case 1
A 44-year-old female patient is scheduled for a lumbar microdiscectomy at L4-5. The patient's clinical and neurological examination does not reveal a motor deficit, but does reveal significant disability in terms of VAS back and leg pain (both 6/10) scores and remarkable impairment in function and HRQoL. Her preoperative TUG Test time is 12.53 s (z score of 2.75 and t score of 127.50). Thus, she is classified as having mild OFI. 7 Surgery is uneventful, and on D3, her D3 TUG Test time is 7.53 s, which is 5 s faster than preoperatively. At D3, this patient can already be considered a responder to treatment.
Case 2
A 70-year-old male patient is scheduled to undergo selective decompression with undercutting at L3-4 for degenerative lumbar spinal stenosis. He presents without motor deficit, but with classic neurogenic claudication. His preoperative TUG Test time is 18.36 s (z score of 5.22 and t score of 152.25), which classifies him as having moderate OFI. 7 Subsequent surgery is performed without complications, but on D3, his TUG Test time is 30 s. At this early point in time/FU, the patient clearly is a nonresponder, if not a negative responder, in terms of TUG Test metrics. In addition, the PROs confirm increased disability (Table 3) . We saw the patient again at the W6 FU in our outpatient clinic. His W6 TUG Test time was 7.83 s (z score of 0.76 and t score of 107.63), which is an improvement of 10.53 s compared with baseline. Using the MCID of 3.4 s, this patient can now be considered a treatment responder in terms of TUG Test metrics at W6, although the PROs still show some impairment.
Even though the mean MCID is 3.4 s, we noticed a large range of 0.9 to 6.0 s depending on the respective subjective scale and computation method used (Table 2 ). This is in line with the literature, which reports a large variability of reported MCIDs due to a variety of methods used to calculate MCIDs. This range of values stems from the fact that there is no gold standard measure of change, and thus many different theories exist on how to best estimate and measure the concept of change. Currently, there is no consensus on which is the superior method. 1 The previously mentioned range suggests that the true value of the change lies somewhere between 0.9 and 6 s, but the greatest likelihood is that it should lie at ∼3.4 s. Given this range, it is feasible that, on further research, the MCID may change as estimates improve in accuracy or a single method becomes accepted. The application of confidence intervals to the range of MCIDs presented here is not appropriate because the many MCIDs generated do not represent sampling distributions.
We would like to take the opportunity to emphasize that that the anchors used (gold standard) were based on PROs, and PROs measure different dimensions than the objective outcome measures used in this study. Other methods, such as using the SE of measurement, may be useful to validate the previously mentioned MCIDs, and further work on this aspect is ongoing.
TUG Test time measurements after surgery is an important issue that should be mentioned. The variation of TUG 3 days after surgery was quite large for the current sample of 100 patients: the mean change in TUG was −0.66 s, and the range was −20.3 to 18.5 s. Applying the MCID of 3.4 s, only 14% of patients would be considered to be responders to surgery at D3 on the objective scale using the TUG Test. The responder rate early after surgery may be higher when subjective scales are used. Our current data show responder rates ranging from 8% (SF-12 PCS), 34% (RMDI), 49% (ODI), 54% (VAS back pain score) up to 79% (VAS leg pain score) as determined by the MCID of each scale, respectively. We concluded that on D3, patients clearly experience relief from preoperative irradiating pain and/or are already experiencing some extent of neurological recovery. The psychological effect of having undergone successful surgery may further factor into the patient's subjective perception of pain. The TUG Test here demonstrates what physicians and health care workers experience in the daily care of patients after lumbar spine surgery: despite feeling better, walking ability and mobility are still greatly constrained. Thus, a clinically meaningful change in the TUG Test metric is rather difficult to obtain in the early postoperative period and should be reserved for medium-and long-term FU. At the W6 FU assessment, the mean change in TUG Test time was −3.5 s, with a range of −20.6 to 11.1 s. According to the average MCID of 3.4 s, 38% of the current sample would be considered treatment responders on the TUG Test, whereas 62% of patients would be classified as nonresponders. Comparing this with the subjective scales, on which W6 FU responder rates ranged from 29% (SF-12 PCS) to 82% (VAS leg pain score), may indicate that recovery of measurable function is still in process at W6. Long-term data will shed more light on the dynamics of recovery of patients with DDD on the TUG Test metric.
CONCLUSION
The MCID for the TUG Test time is highly variable depending on the computation technique used. Using all 3 methods and all anchors, the suggested TUG MCID to be used in future studies is 3.4 s. The obtained MCID values confirm our personal experience of clinically meaningful recovery from patient FU in clinical daily routine.
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of lumbar spine surgeries were examined. Standard patient-reported outcome (PRO) measures, as well as the TUG test, were gathered preoperatively and at intervals postoperatively. Using various PROs as anchors, and using 3 different methodologies, the MCID for the TUG test was calculated.
The results showed a mean MCID for the TUG test of 3.4 seconds. Values ranged from 0.9 seconds to 6.0 seconds, highlighting the spectrum of results that can be obtained with the various anchors and methodologies.
These results provide further insight into the potential clinical usefulness of the TUG test in lumbar spine surgery. The authors have also illustrated in their analysis the heterogeneity of calculated MCID values, even using sound statistical methods. This heterogeneity speaks to the need for an agreed-upon methodology for generating these important parameters, especially in the current era of value-based care.
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